These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 9002527

  • 21. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A.
    BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Nephrology (Carlton); 2007 Jun 31; 12(3):285-8. PubMed ID: 17498124
    [Abstract] [Full Text] [Related]

  • 25. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations.
    Greenberg A, Bastacky SI, Iqbal A, Borochovitz D, Johnson JP.
    Am J Kidney Dis; 1997 Mar 31; 29(3):334-44. PubMed ID: 9041208
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A clinicopathological and prognostic study of 18 children with C1q nephropathy and focal segmental glomerulosclerosis: an 18-year experience from a single center.
    Peng Y, Ju T, Gao C, Xia Z, Wang M, Sun X, Wang R, Li X, Wei Y, Jia L, Chen H.
    J Nephrol; 2023 Jul 31; 36(6):1615-1625. PubMed ID: 37428438
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
    Roja JR, Pérez M, Hurtado A, Asato C.
    Nefrologia; 2008 Jul 31; 28(4):439-46. PubMed ID: 18662153
    [Abstract] [Full Text] [Related]

  • 34. Comparison of tubular proteinuria, using sodium dodecyl sulphate polyacrylamide gel electrophoresis, in patients during methotrexate or aminoglycoside treatment or with cadmium or Balkan nephropathy.
    Fleming JJ.
    Clin Chim Acta; 1984 Jul 31; 140(3):267-77. PubMed ID: 6467614
    [Abstract] [Full Text] [Related]

  • 35. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L, Italian Society of Nephrology.
    G Ital Nefrol; 2003 Jul 31; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [Abstract] [Full Text] [Related]

  • 36. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Jul 31; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.
    Cytokine; 2015 Dec 31; 76(2):260-269. PubMed ID: 26307557
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG, Cameron JS, Turner DR, Evans DJ, White RH, Ogg CS, Chantler C, Brown CB.
    Q J Med; 1975 Apr 31; 44(174):207-39. PubMed ID: 1178811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.